Centessa Pharmaceuticals
Executivos
Veja o organograma con seus 19 executivos principais
Biografias mais buscadas da Centessa Pharmaceuticals
- Saurabh Saha, Chief Executive Officer and Director
- Francesco De Rubertis, Chairman of The Board
- Mary Hedley, Director
Recentes movimentos de executivos em Centessa Pharmaceuticals
- Ellie Im, ingressou na Companhia como Senior Vice President of Clinical Development, Oncology (Notícia publicada em 3 de outubro de 2023).
- April Dovholuk, ingressou na Companhia como Senior Vice President of Development Operations (Notícia publicada em 3 de outubro de 2023).
Criar um alerta
para seguir os movimentos de executivos da Centessa Pharmaceuticals.
Farmacêutica
Centessa Pharmaceuticals possui 1.860 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Centessa Pharmaceuticals
- Centessa Pharmaceuticals Announces Addition of Harris L. Rotman, PhD, as Senior Vice President of Regulatory Affairs | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors | Centessa Pharmaceuticals
- Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Announces Poster Presentation of First Preclinical Data for LockBody® Program at 2022 ASCO Annual Meeting | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Makes Strategic Decision to Discontinue Clinical Development of Lixivaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updates | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Doses First Subject in Global Phase 3 ACTION Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise | Centessa Pharmaceuticals
- Centessa Pharmaceuticals to Present at the Guggenheim Genomic Medicines & Rare Disease Day | Centessa Pharmaceuticals
- View more press releases Close
Redes sociais sobre Centessa Pharmaceuticals
- Centessa Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Centessa Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Saurabh Saha 
Ligue para a Centessa Pharmaceuticals em +1 857...
